ATE323886T1 - Verfahren zur diagnose der alzheimerschen krankheit - Google Patents
Verfahren zur diagnose der alzheimerschen krankheitInfo
- Publication number
- ATE323886T1 ATE323886T1 AT02705902T AT02705902T ATE323886T1 AT E323886 T1 ATE323886 T1 AT E323886T1 AT 02705902 T AT02705902 T AT 02705902T AT 02705902 T AT02705902 T AT 02705902T AT E323886 T1 ATE323886 T1 AT E323886T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- diagnosing alzheimer
- glycoproteins
- dementia
- diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
- G01N2333/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26384101P | 2001-01-23 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE323886T1 true ATE323886T1 (de) | 2006-05-15 |
Family
ID=23003453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02705902T ATE323886T1 (de) | 2001-01-23 | 2002-01-23 | Verfahren zur diagnose der alzheimerschen krankheit |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20020150878A1 (de) |
| EP (1) | EP1356299B1 (de) |
| AT (1) | ATE323886T1 (de) |
| CA (1) | CA2442708A1 (de) |
| DE (1) | DE60210741D1 (de) |
| WO (1) | WO2002059619A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020033126A (ko) * | 2002-03-08 | 2002-05-04 | 김용선 | 병원성 프리온 단백의 n말단의 비효소적 당화반응 최종산물의 검출에 의한 프리온 질환의 진단 |
| GB0508863D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Peptide |
| CL2007002908A1 (es) | 2007-10-09 | 2008-05-30 | Univ Concepcion | Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg |
| ES2889914B2 (es) * | 2020-07-01 | 2022-07-21 | Univ Miguel Hernandez De Elche | PATRON DE GLICOSILACION DE sAPPalfa Y/O sAPPbeta COMO BIOMARCADOR DIAGNOSTICO DE LA ENFERMEDAD DE ALZHEIMER, METODO Y KIT BASADOS EN EL MISMO |
| WO2022042873A1 (en) | 2020-08-27 | 2022-03-03 | Immunologik Gmbh | Pharmaceutically acceptable lectins derived from plants, fungi and bacteria for the treatment of sars-cov-2 infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1313496C (en) * | 1988-04-29 | 1993-02-09 | James Wilson Dennis | Diagnostic method to screen tumors |
| AUPO943297A0 (en) * | 1997-09-24 | 1997-10-16 | University Of Melbourne, The | Diagnostic test for alzheimer's disease |
| AU2001259046A1 (en) * | 2000-04-07 | 2001-10-23 | Monash University | Diagnostic test for alzheimer's disease |
-
2002
- 2002-01-17 US US10/051,653 patent/US20020150878A1/en not_active Abandoned
- 2002-01-23 EP EP02705902A patent/EP1356299B1/de not_active Expired - Lifetime
- 2002-01-23 WO PCT/US2002/001874 patent/WO2002059619A2/en not_active Ceased
- 2002-01-23 AT AT02705902T patent/ATE323886T1/de not_active IP Right Cessation
- 2002-01-23 DE DE60210741T patent/DE60210741D1/de not_active Expired - Lifetime
- 2002-01-23 CA CA002442708A patent/CA2442708A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020150878A1 (en) | 2002-10-17 |
| WO2002059619A3 (en) | 2002-10-17 |
| CA2442708A1 (en) | 2002-08-01 |
| EP1356299A2 (de) | 2003-10-29 |
| EP1356299B1 (de) | 2006-04-19 |
| WO2002059619A2 (en) | 2002-08-01 |
| DE60210741D1 (de) | 2006-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE526041T1 (de) | Verfahren zur hemmung okularer vorgänge | |
| CY1112579T1 (el) | Μεθοδοι και συνθεσεις για τη διαγνωση του ηλικιακου εκφυλισμου της ωχρας κηλιδας | |
| MA29528B1 (fr) | Agents de fixation | |
| IN2014DN05011A (de) | ||
| ATE404118T1 (de) | System für kontinuierliche leistungstests | |
| ATE433163T1 (de) | Verfahren zur vorhersage der behandlungsresultate | |
| WO2005042761A3 (en) | Biomarkers for amyotrophic lateral sclerosis | |
| ATE324624T1 (de) | Verfahren zur prozessgesteuerten und kundenindividuellen herstellung eines gegenstandes | |
| WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
| AU2003259222A1 (en) | Method of diagnosing alzheimer's disease | |
| WO2004107958A3 (en) | Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | |
| ATE323886T1 (de) | Verfahren zur diagnose der alzheimerschen krankheit | |
| WO2006014755A3 (en) | Methods of identifying patients at risk of developing encephalitis following immunotherapy for alzheimer’s disease | |
| FI20031370A0 (fi) | Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan | |
| ATE465408T1 (de) | Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins | |
| AU2002238766A1 (en) | Diagnostic screens for alzheimer's disease | |
| ATE391954T1 (de) | Verfahren zur steuerung eines ressourcenzugriffs eines prozesses durch einen elternprozess | |
| DE60137513D1 (de) | Methode zur Diagnose von oder zur Bestimmung des Risikos für Psychose beinhaltend die Bestimmung einer heterozygoten Mutation der Methylentetrahydrolfolatreduktase (MTHFR) | |
| WO2003074558A3 (en) | Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom | |
| WO2001085980A3 (en) | Enzymatic assays for screening anti-cancer agents | |
| DE602004030819D1 (de) | Angiogenesehemmende moleküle und ihre verwendung bei der behandlung und diagnose von krebs | |
| WO2006121912A3 (en) | Diagnostic methods for the detection of risk of neurodevelopmental disorders | |
| DE50007635D1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| WO2004031912A3 (en) | Methods for estimating haplotype frequencies and disease associations with haplotypes and environmental variables | |
| WO2004098391A3 (en) | Methods for detecting parvovirous infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |